Patents by Inventor Marlin O. Thurston

Marlin O. Thurston has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8475763
    Abstract: A method for detecting antigen associated with adenocarcinoma commences by forming a 124I conjugate of a preferential locator, such as an antibody, and introducing the conjugate into a patient suspected of having adenocarcinoma. Positron emission tomography (PET) scanning of the patient reveals sites of accumulated conjugate, such sites including lymph nodes. The course of treatment of the patient then is determined by the amount of revealed lymph nodes.
    Type: Grant
    Filed: October 9, 2008
    Date of Patent: July 2, 2013
    Assignee: Actis, Ltd.
    Inventor: Marlin O. Thurston
  • Publication number: 20110233421
    Abstract: A radiation-detecting probe instrument has a forward working portion housing a radiation detector and a rearward user directed portion, and is in communication with a control assembly for processing and outputting signals received from the radiation detector correlative to a located radionuclide source emitting energy above 88 KeV (for Pb). The disclosed probe instrument forward portion has an annular housing having a radiation transparent tip. The radiation detector is disposed behind the radiation transparent tip. A characteristic x-ray radiation emitting wafer (e.g., Pb) is disposed either between or behind the radiation transparent tip and the radiation detector. A radiation resistant (e.g., W) shield is disposed between the annular housing and the radiation detector and the characteristic x-ray emission wafer.
    Type: Application
    Filed: March 31, 2011
    Publication date: September 29, 2011
    Applicant: ACTIS, LTD
    Inventors: Marlin O. Thurston, Richard B. Thurston
  • Publication number: 20100249583
    Abstract: A radiation-detecting probe instrument has a forward working portion housing a radiation detector and a rearward user directed portion, and is in communication with a control assembly for processing and outputting signals received from the radiation detector correlative to a located radionuclide source emitting energy above about 80 KeV. The disclosed probe instrument forward portion has an annular housing having a radiation transparent tip. The radiation detector is disposed behind the radiation transparent tip. A K alpha radiation emitting wafer (e.g., Pb) wafer is disposed between the radiation transparent tip and the radiation detector. A radiation resistant (e.g., W) shield is disposed between the annular housing and the radiation detector and the Pb wafer. Radiation emitted from the radionuclide source strikes the Pb wafer causing the Pb wafer to emit K alpha radiation, which strikes the radiation detector for generating signals for communication the said control assembly.
    Type: Application
    Filed: March 24, 2010
    Publication date: September 30, 2010
    Applicant: ACTIS, LTD
    Inventors: Marlin O. Thurston, Richard B. Thurston
  • Patent number: 7738946
    Abstract: System, method and apparatus wherein a probe employing non-imagining optics is utilized in conjunction with a fluorescing (e.g., nanocrystal) tracer at the body of a patient. Excitation components within the probe working end are utilized to excite the nanocrystals to fluoresce at wavelengths in the near infrared region, such fluorescent energy is homogenized by interacting with involved tissue to provide a uniform fluorescing intensity over the surface of a photo-detector. Initialization and background determination procedures are described along with a technique for determining statistically significant levels of fluorescing activity.
    Type: Grant
    Filed: October 3, 2007
    Date of Patent: June 15, 2010
    Assignee: Actis, Ltd.
    Inventors: Marlin O. Thurston, Helen Thurston, legal representative, Karl W. Olson
  • Publication number: 20100092392
    Abstract: A method for detecting antigen associated with adenocarcinoma commences by forming a 124I conjugate of a preferential locator, such as an antibody, and introducing the conjugate into a patient suspected of having adenocarcinoma. Positron emission tomography (PET) scanning of the patient reveals sites of accumulated conjugate, such sites including lymph nodes. The course of treatment of the patient then is determined by the amount of revealed lymph nodes.
    Type: Application
    Filed: October 9, 2008
    Publication date: April 15, 2010
    Applicant: ACTIS, LTD
    Inventor: Marlin O. Thurston
  • Patent number: 7689269
    Abstract: System, method and apparatus wherein a probe employing non-imagining optics is utilized in conjunction with a fluorescing nanocrystal tracer at the body of a patient. Excitation components within the probe working end are utilized to excite the nanocrystals to fluoresce at wavelengths in the near infrared region, such fluorescent energy is homogenized by interacting with involved tissue to provide a uniform fluorescing intensity over the surface of a photo-detector. Initialization and background determination procedures are described along with a technique for determining statistically significant levels of fluorescing activity.
    Type: Grant
    Filed: May 10, 2007
    Date of Patent: March 30, 2010
    Assignee: Actis, Ltd.
    Inventors: Marlin O. Thurston, Karl W. Olson
  • Publication number: 20090208417
    Abstract: A method for detecting gold or other nanoparticles conjugated to preferential locators commences by contacting tissue suspected of being neoplastic with gold nanoparticle/preferential locator conjugates for a time adequate for the conjugates to bind with the tissue. A beam of gamma photons (such as from, 99mTc) is directed at the conjugate bound tissue to remove electrons from the K-shell or L-shell, for example, of the gold nanoparticles. The removed electrons can be detected for locating neoplastic tissue or X-ray fluorescence corresponding to an electron transitioning from one shell to another shell can be detected, or by detecting resulting X-ray fluorescence corresponding to an electron transitioning from one shell to another shell, such as X-ray fluorescence arising from K-alpha emission corresponding to an electron transitioning from the L shell to the K shell. Additional X-ray fluorescing detecting molecules include Ag, I, Fe, Tc, Zn, Mn, Cr (trivalent).
    Type: Application
    Filed: February 5, 2009
    Publication date: August 20, 2009
    Applicants: Actis, Ltd, The Ohio State University
    Inventors: Marlin O. Thurston, Vishwanath V. Subramaniam
  • Publication number: 20080281172
    Abstract: System, method and apparatus wherein a probe employing non-imagining optics is utilized in conjunction with a fluorescing nanocrystal tracer at the body of a patient. Excitation components within the probe working end are utilized to excite the nanocrystals to fluoresce at wavelengths in the near infrared region, such fluorescent energy is homogenized by interacting with involved tissue to provide a uniform fluorescing intensity over the surface of a photo-detector. Initialization and background determination procedures are described along with a technique for determining statistically significant levels of fluorescing activity.
    Type: Application
    Filed: May 10, 2007
    Publication date: November 13, 2008
    Applicant: Actis, Ltd.
    Inventors: Marlin O. Thurston, Karl W. Olson
  • Publication number: 20080281208
    Abstract: System, method and apparatus wherein a probe employing non-imagining optics is utilized in conjunction with a fluorescing (e.g., nanocrystal) tracer at the body of a patient. Excitation components within the probe working end are utilized to excite the nanocrystals to fluoresce at wavelengths in the near infrared region, such fluorescent energy is homogenized by interacting with involved tissue to provide a uniform fluorescing intensity over the surface of a photo-detector. Initialization and background determination procedures are described along with a technique for determining statistically significant levels of fluorescing activity.
    Type: Application
    Filed: October 3, 2007
    Publication date: November 13, 2008
    Applicant: Actis, Ltd.
    Inventors: Marlin O. Thurston, Helen Thurston, Karl W. Olson
  • Patent number: 6749750
    Abstract: A magnetic sheet assembly for application to a device adapted for magnetic separation, the magnetic sheet assembly comprising: a magnetic sheet; a permanent, pressure sensitive adhesive; a carrier sheet; and a non-permanent pressure sensitive adhesive. Also provided is a method of mounting and removably adhering the magnetic sheet assembly to a surface of a device for magnetic separation, the method comprising the steps of aligning the magnetic sheet assembly with the surface of the device; and pressing the aligned magnetic sheet assembly in placing its non-permanent adhesive face into adhesive contact with the surface of the device.
    Type: Grant
    Filed: October 11, 2001
    Date of Patent: June 15, 2004
    Assignee: Biocrystal Ltd.
    Inventors: Emilio Barbera-Guillem, Marlin O. Thurston
  • Publication number: 20020084880
    Abstract: A magnetic sheet assembly for application to a device adapted for magnetic separation, the magnetic sheet assembly comprising: a magnetic sheet; a permanent, pressure sensitive adhesive; a carrier sheet; and a non-permanent pressure sensitive adhesive. Also provided is a method of mounting and removably adhering the magnetic sheet assembly to a surface of a device for magnetic separation, the method comprising the steps of aligning the magnetic sheet assembly with the surface of the device; and pressing the aligned magnetic sheet assembly in placing its non-permanent adhesive face into adhesive contact with the surface of the device.
    Type: Application
    Filed: October 11, 2001
    Publication date: July 4, 2002
    Inventors: Emilio Barbera-Guilem, Marlin O. Thurston
  • Patent number: 6222193
    Abstract: A hand-held surgical probe is provided with a crystal detector mount architecture wherein a rigid mounting of key components is achieved. In one embodiment, the crystal detector mount is supported and suspended by a vibration damping suspension externally located with respect to the crystal detector mount. The crystal detector mount architecture and vibration damping suspension act to reduce a variety of noise phenomena.
    Type: Grant
    Filed: October 6, 1998
    Date of Patent: April 24, 2001
    Assignee: Neoprobe Corporation
    Inventors: Marlin O. Thurston, Karl W. Olson
  • Patent number: 6191422
    Abstract: A hand-held radiation probe is configured having a crystal thickness as well as a bias generated electrical field which have values to cause the semiconductor crystal to operate in a trapping-dependent operational mode wherein a trapping of substantially all carriers generated by radiation impinging upon the crystal forward face are trapped. The bias level voltage is selected to achieve adequate photopeak heights and to permit the windowing out of lower energy Compton scattering and other noise phenomena.
    Type: Grant
    Filed: October 6, 1998
    Date of Patent: February 20, 2001
    Assignee: Neoprobe Corporation
    Inventor: Marlin O. Thurston
  • Patent number: 6179912
    Abstract: Provided is a system and continuous flow process for producing monodisperse semiconductor nanocrystals comprising reservoirs for the starting materials, a mixing path in which the starting materials are mixed, a first reactor in which the mixture of starting materials is mixed with a coordinating solvent and in which nucleation of particles occurs, a second reactor in which controlled growth of the nanocrystals occurs, and a growth termination path in which the growth of the nanocrystals is halted.
    Type: Grant
    Filed: December 20, 1999
    Date of Patent: January 30, 2001
    Assignee: BioCrystal Ltd.
    Inventors: Emilio Barbera-Guillem, Marlin O. Thurston
  • Patent number: 6126835
    Abstract: Provided is a magnetic separation device comprising a container having one or more outer surfaces; at least one magnetic sheet; and a physical coupler that is used to detachably secure the container to the magnetic sheet.
    Type: Grant
    Filed: February 1, 1999
    Date of Patent: October 3, 2000
    Assignee: BioCrystal Ltd.
    Inventors: Emilio Barbera-Guillem, Marlin O. Thurston
  • Patent number: 5987350
    Abstract: A surgical probe wherein a heat sterilizable and reusable detector component is combined with a disposable handle and cable assembly. The reusable detector component incorporates a detector crystal and associated mountings along with preamplifier components. It is formed having a positioning shaft extending therefrom to a contact supporting surface carrying a pattern of electrical contact surfaces. The disposable handle employs an insert member having a receiving cavity. The electrical contact carrying tip of the shaft moves into electrical engagement with a pattern of electrical contacts mounted within the handle in conjunction with a permanently affixed flexible cable.
    Type: Grant
    Filed: October 10, 1997
    Date of Patent: November 16, 1999
    Assignee: Neoprobe Corporation
    Inventor: Marlin O. Thurston
  • Patent number: 5857463
    Abstract: System and apparatus particularly suited for tracking a radiopharmaceutical present within a lymph duct and locating a sentinel node within which the radiopharmaceutical has concentrated. A smaller, straight, hand-held probe is employed carrying two hand actuable switches. For tracking procedures, the probe is moved in an undulatory manner wherein the location of the radiopharmaceutical containing duct is determined by observing a graphics readout developed preferably employing a circularly accessed data memory. When the region of the sentinel node is approached, a switch on the probe device is actuated by the surgeon to carry out a sequence of squelching operations until a small node locating region is defined. At that point in the procedure, the straight small probe will be pointed at and in adjacency with the radiopharmaceutical containing sentinel node. The probe-mounted switches are configured to apply preset current levels upon the probe pre-amplifier power supply.
    Type: Grant
    Filed: October 13, 1995
    Date of Patent: January 12, 1999
    Assignee: Neoprobe Corporation
    Inventors: Marlin O. Thurston, Karl W. Olson
  • Patent number: 5732704
    Abstract: The method for identifying a sentinel lymph node located within a grouping of regional nodes at a lymph draininage basin associated with neoplastic tissue wherein a radiopharmaceutical is injected at the situs of the neoplastic tissue. This radiopharmaceutical migrates along a lymph duct toward the drainage basin containing the sentinel node. A hand-held probe with a forwardly disposed radiation detector crystal is maneuvered along the duct while the clinician observes a graphical readout of count rate amplitudes to determine when the probe is aligned with the duct. The region containing the sentinel node is identified when the count rate at the probe substantially increases. Following incision, the probe is maneuvered utilizing a sound output in connection with actuation of the probe to establish increasing count rate thresholds followed by incremental movements until the threshold is not reached and no sound cue is given the surgeon.
    Type: Grant
    Filed: October 13, 1995
    Date of Patent: March 31, 1998
    Assignee: Neoprobe Corporation
    Inventors: Marlin O. Thurston, Karl W. Olson, Richard C. Orahood, Michael D. Magill
  • Patent number: 5682888
    Abstract: A probe instrument which is formed having a unitary housing with indented switch actuating surfaces intended for surgical procedures employs internally disposed piezoelectric switching components within an elongate internally disposed switch receiving channel. The forward end of the instrument supports a crystal containing detector assembly with a preamplifier and associated leads which extend within a detector signal channel spaced from the switch receiving channel and protected therefrom by a shield wall. The piezoelectric components are held in preloaded association adjacent outwardly disposed switch actuating surfaces by a dual wedge switch support assembly. An elongate cable is permanently attached to the rearward end of the housing component through the utilization of a medical grade silicone seal and relief component.
    Type: Grant
    Filed: June 13, 1996
    Date of Patent: November 4, 1997
    Assignee: Neoprobe Corporation
    Inventors: Karl W. Olson, Marlin O. Thurston
  • Patent number: 5495111
    Abstract: Intended for use in a pathology laboratory, the apparatus includes a multi-segment crystal array over which is positioned a platform supported receiving region with a pattern carrying indicia emulating and in registry with the pattern of the crystal array segments. The tissue carrying a radiolabeled locator is positioned on the receiving region and the photon emission count values for each segment are compiled and displayed at a computer monitor or as a print-out in conjunction with crystal segment identification. Observation of the count values by a pathologist then shows the location over a segment of highest count value at which locator is more likely to be concentrated. Sectioning then is carried out at that location.
    Type: Grant
    Filed: October 26, 1994
    Date of Patent: February 27, 1996
    Assignee: Neoprobe Corporation
    Inventors: Marlin O. Thurston, Karl W. Olson